文献速递临床试验与 GCP真实世界研究与卫生经济

远程医疗支持的生活方式干预用于冠心病合并2型糖尿病患者血糖控制:多中心随机对照试验

Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial.
PubMed 文献 · Nat Med · 2025-02-07

这项多中心1:1随机对照试验纳入502例冠心病合并2型糖尿病患者(68±8岁,84%为男性),评估居家远程医疗支持的生活方式干预(运动训练、营养建议和健康素养培训)加定期个体化反馈与常规照护相比的效果。6个月时干预组糖化血红蛋白降低达到主要终点(完全病例分析组间平均差异-0.13%,95%CI -0.25至-0.01,P=0.04);6个月后停止个体化反馈和健康素养培训(保留其他远程医疗工具)时,12个月未观察到统计学显著的组间差异。

要点

  • 6个月时生活方式干预组糖化血红蛋白较常规照护组降低,组间平均差异-0.13%(95%CI -0.25至-0.01,P=0.04)。
  • 12个月时主要不良心血管事件:生活方式干预组20例(8.0%)vs 常规照护组11例(4.4%),P=0.15。
  • 5例死亡(生活方式干预组2例,常规照护组3例),均未归类为与干预相关。

核心结论

  • 居家远程医疗支持的生活方式干预在冠心病合并2型糖尿病患者中显示出适度效果。

研究设计与样本

  • 多中心、1:1随机对照试验,纳入502例冠心病合并2型糖尿病患者(68±8岁;84%为男性)。
  • 比较居家远程医疗支持的生活方式干预(运动训练、营养建议和健康素养培训)加定期个体化反馈与常规照护。

主要发现

  • 6个月时糖化血红蛋白组间平均差异(完全病例分析,n=197和n=193)为-0.13%(95%CI -0.25至-0.01),P=0.04,达到主要终点。
  • 6个月后停止个体化反馈和健康素养培训(保留其他远程医疗工具)时,12个月未观察到统计学显著的组间差异。
  • 12个月时31例(6.2%)发生主要不良心血管事件:生活方式干预组20例(8.0%)vs 常规照护组11例(4.4%),P=0.15;主要原因为心绞痛或血运重建住院(生活方式干预组15例,常规照护组8例)。
  • 5例死亡(生活方式干预组2例,常规照护组3例),均未归类为与干预相关。
  • 3例导致住院的事件被归类为可能与干预相关(心力衰竭失代偿、椎间盘脱出和腹股沟疝)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients with coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM) have a substantially increased risk for major cardiovascular events and mortality. Increasing physical activity and improving a healthy diet may effectively reduce cardiovascular risk factors; however, the effects are often transient. In a multicenter, 1:1 randomized controlled trial including 502 patients with combined CHD and T2DM (68 ± 8 years; 84% men), we assessed the effects of a home-based telemedicine-supported lifestyle intervention (exercise training, nutritional recommendations and health literacy training) with regular individualized feedback versus usual care. The study met its primary endpoint of reduced glycated hemoglobin after 6 months in favor of the lifestyle intervention group (mean between-group difference in the complete-case analysis (n = 197 and n = 193), -0.13% (95% confidence interval, -0.25 to -0.01), P = 0.04). When individualized feedback and health literacy training were discontinued after 6 months (while other telemedicine tools were maintained), no statistically significant between-group differences were observed at 12 months. At 12 months, 31 patients (6.2%) had a major adverse cardiovascular event (lifestyle intervention, n = 20 (8.0%); usual care, n = 11 (4.4%); P = 0.15), with the main reason being hospitalization for angina or revascularization (lifestyle intervention, n = 15; usual care, n = 8). There were five deaths (lifestyle intervention, n = 2; usual care, n = 3), none of which were categorized as related to the intervention. However, three events that resulted in hospitalization were categorized as potentially related to the intervention (decompensation of heart failure, vertebral disc prolapse and inguinal hernia). In conclusion, a home-based lifestyle intervention with telemedicine support showed modest effects in patients with CHD and T2DM. ClinicalTrials.gov registration: NCT03835923 .

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Mueller S, Dinges SMT, Gass F, et al. Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial. Nat Med. 2025. PMID: 39920395. doi:10.1038/s41591-025-03498-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。